FDA warns Philips Respironics on malfunction reporting

The FDA issues a warning letter to Philips Respironics over how it reports and addresses ventilator malfunctions.

Royal Philips's (NYSE:PHG) subsidiary Philips Respironics got another warning letter from the FDA for falling short on how it reports and addresses malfunctions.

Food & Drug Administration (FDA), Philips

News Well, Recalls, Regulatory/Compliance, Respiratory

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1CvAAMf